Fifth Third Bancorp’s Accendra Health ACH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.28K | Sell |
1,544
-13
| -0.8% | -$40 | ﹤0.01% | 3913 |
|
|
2026
Q1 | $3.55K | Hold |
1,557
| – | – | ﹤0.01% | 3940 |
|
|
2025
Q4 | $4.36K | Sell |
1,557
-47
| -3% | -$168 | ﹤0.01% | 2327 |
|
|
2025
Q3 | $7.7K | Sell |
1,604
-236
| -13% | -$1.5K | ﹤0.01% | 2217 |
|
|
2025
Q2 | $16.7K | Sell |
1,840
-136
| -7% | -$1K | ﹤0.01% | 1839 |
|
|
2025
Q1 | $17.8K | Buy |
1,976
+402
| +26% | +$4.24K | ﹤0.01% | 1799 |
|
|
2024
Q4 | $20.6K | Sell |
1,574
-209
| -12% | -$2.79K | ﹤0.01% | 1739 |
|
|
2024
Q3 | $28K | Buy |
1,783
+73
| +4% | +$1.11K | ﹤0.01% | 1657 |
|
|
2024
Q2 | $23.1K | Sell |
1,710
-32
| -2% | -$655 | ﹤0.01% | 1673 |
|
|
2024
Q1 | $48.3K | Buy |
1,742
+6
| +0.3% | +$133 | ﹤0.01% | 1352 |
|
|
2023
Q4 | $33.5K | Buy |
1,736
+65
| +4% | +$1.18K | ﹤0.01% | 1556 |
|
|
2023
Q3 | $27K | Sell |
1,671
-202
| -11% | -$3.58K | ﹤0.01% | 1622 |
|
|
2023
Q2 | $35.7K | Buy |
1,873
+90
| +5% | +$1.6K | ﹤0.01% | 1500 |
|
|
2023
Q1 | $25.9K | Buy |
1,783
+139
| +8% | +$2.49K | ﹤0.01% | 1720 |
|
|
2022
Q4 | $32.1K | Buy |
1,644
+494
| +43% | +$9.63K | ﹤0.01% | 1515 |
|
|
2022
Q3 | $28K | Sell |
1,150
-69
| -6% | -$2.13K | ﹤0.01% | 1565 |
|
|
2022
Q2 | $38K | Sell |
1,219
-103
| -8% | -$3.73K | ﹤0.01% | 1480 |
|
|
2022
Q1 | $58K | Buy |
1,322
+5
| +0.4% | +$215 | ﹤0.01% | 1395 |
|
|
2021
Q4 | $57K | Buy |
1,317
+68
| +5% | +$2.67K | ﹤0.01% | 1466 |
|
|
2021
Q3 | $39K | Buy |
1,249
+99
| +9% | +$3.9K | ﹤0.01% | 1547 |
|
|
2021
Q2 | $49K | Hold |
1,150
| – | – | ﹤0.01% | 1459 |
|
|
2021
Q1 | $43K | Hold |
1,150
| – | – | ﹤0.01% | 1497 |
|
|
2020
Q4 | $31K | Sell |
1,150
-1,150
| -50% | -$29.6K | ﹤0.01% | 1563 |
|
|
2020
Q3 | $58K | Sell |
2,300
-150
| -6% | -$2.19K | ﹤0.01% | 1282 |
|
|
2020
Q2 | $19K | Hold |
2,450
| – | – | ﹤0.01% | 1561 |
|
|
2020
Q1 | $22K | Buy |
2,450
+2,300
| +1,533% | +$13.9K | ﹤0.01% | 1502 |
|
|
2019
Q4 | $1K | Buy |
+150
| New | +$963 | ﹤0.01% | 2147 |
|
|
2019
Q3 | – | Sell |
-106
| Closed | – | – | 2292 |
|
|
2019
Q2 | $0 | Buy |
+106
| New | +$362 | ﹤0.01% | 2334 |
|
|
2016
Q1 | – | Sell |
-176
| Closed | -$6K | – | 2578 |
|
|
2015
Q4 | $6K | Sell |
176
-225
| -56% | -$8.14K | ﹤0.01% | 2139 |
|
|
2015
Q3 | $13K | Buy |
401
+204
| +104% | +$6.95K | ﹤0.01% | 1928 |
|
|
2015
Q2 | $7K | Buy |
197
+84
| +74% | +$2.83K | ﹤0.01% | 2210 |
|
|
2015
Q1 | $4K | Buy |
113
+22
| +24% | +$766 | ﹤0.01% | 2294 |
|
|
2014
Q4 | $3K | Sell |
91
-292
| -76% | -$9.83K | ﹤0.01% | 2190 |
|
|
2014
Q3 | $13K | Sell |
383
-500
| -57% | -$17K | ﹤0.01% | 1906 |
|
|
2014
Q2 | $30K | Hold |
883
| – | – | ﹤0.01% | 1639 |
|
|
2014
Q1 | $31K | Buy |
883
+308
| +54% | +$10.9K | ﹤0.01% | 1619 |
|
|
2013
Q4 | $21K | Buy |
575
+75
| +15% | +$2.75K | ﹤0.01% | 1648 |
|
|
2013
Q3 | $17K | Hold |
500
| – | – | ﹤0.01% | 1722 |
|
|
2013
Q2 | $17K | Buy |
+500
| New | +$16.6K | ﹤0.01% | 1646 |
|
Other funds holding ACH
CCM
ICM
PCMI
Fifth Third Bancorp's ACH Position: Q2 2026 in Review
Fifth Third Bancorp reduced its Accendra Health (ACH) stake by 0.83% in Q2 2026, selling an estimated $40 and leaving 1,544 shares worth $5.28K. The position accounts for ﹤0.01% of the portfolio, ranked #3913.
Fifth Third Bancorp first reported a position in ACH in Q2 2013 and has held it in 39 quarters since. The position peaked at $58K in Q1 2022. 139 funds tracked by Wall St. Rank hold ACH as of Q2 2026.
- Fifth Third Bancorp held 1,544 shares of Accendra Health worth $5.28K as of Q2 2026.
- Fifth Third Bancorp sold 13 Accendra Health shares in Q2 2026, an estimated $40.
- Accendra Health made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #3913 holding.
- Fifth Third Bancorp first reported a position in Accendra Health in Q2 2013 and has held it in 39 quarters since.
- Fifth Third Bancorp's Accendra Health position peaked at $58K in Q1 2022.
- 139 funds tracked by Wall St. Rank held Accendra Health as of Q2 2026.
Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.